Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | glucosylceramidase, putative | 0.0266 | 0.8692 | 0.9996 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0297 | 1 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0266 | 0.8692 | 0.9996 |
Schistosoma mansoni | glutaminase | 0.0266 | 0.8693 | 1 |
Brugia malayi | glutaminase DH11.1 | 0.0266 | 0.8693 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.0262 | 0.0302 |
Loa Loa (eye worm) | glutaminase | 0.0266 | 0.8693 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0266 | 0.8692 | 0.9996 |
Mycobacterium ulcerans | glutaminase | 0.0266 | 0.8693 | 1 |
Echinococcus multilocularis | geminin | 0.0165 | 0.4499 | 0.7747 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0138 | 0.3371 | 0.3878 |
Schistosoma mansoni | hypothetical protein | 0.0103 | 0.1939 | 0.223 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0138 | 0.3371 | 0.5685 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0266 | 0.8692 | 0.9996 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0184 | 0.5288 | 0.1027 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0103 | 0.1939 | 0.223 |
Trichomonas vaginalis | glutaminase, putative | 0.0266 | 0.8693 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0103 | 0.1939 | 0.223 |
Echinococcus multilocularis | Tolloid protein 1 | 0.0194 | 0.5731 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0138 | 0.3371 | 0.5685 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0151 | 0.392 | 0.4509 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0138 | 0.3371 | 0.5685 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0297 | 1 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0297 | 1 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0138 | 0.3371 | 0.3878 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.0063 | 0.0262 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0184 | 0.5288 | 0.1027 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0138 | 0.3371 | 0.3878 |
Loa Loa (eye worm) | bone morphogenetic protein 1b | 0.0194 | 0.5731 | 0.6593 |
Loa Loa (eye worm) | hypothetical protein | 0.0186 | 0.5403 | 0.6215 |
Schistosoma mansoni | hypothetical protein | 0.0165 | 0.4499 | 0.5175 |
Loa Loa (eye worm) | AStacin protease | 0.0122 | 0.2706 | 0.3112 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0138 | 0.3371 | 0.3878 |
Schistosoma mansoni | subfamily M12A unassigned peptidase (M12 family) | 0.0194 | 0.5731 | 0.6593 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0138 | 0.3371 | 0.5685 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0157 | 0.4159 | 0.5 |
Brugia malayi | Calcium binding EGF domain containing protein | 0.0063 | 0.0262 | 0.0302 |
Schistosoma mansoni | hypothetical protein | 0.0165 | 0.4499 | 0.5175 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0266 | 0.8692 | 0.9996 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0138 | 0.3371 | 0.3878 |
Echinococcus granulosus | Tolloid protein 1 | 0.0194 | 0.5731 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0151 | 0.392 | 0.4509 |
Brugia malayi | O-Glycosyl hydrolase family 30 protein | 0.0266 | 0.8692 | 0.9998 |
Brugia malayi | Fibulin-1 precursor | 0.0063 | 0.0262 | 0.0302 |
Onchocerca volvulus | Glucosylceramidase homolog | 0.0174 | 0.4898 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0266 | 0.8692 | 0.9996 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.0266 | 0.8692 | 0.9998 |
Echinococcus granulosus | geminin | 0.0165 | 0.4499 | 0.7747 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.0063 | 0.0262 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0151 | 0.392 | 0.4509 |
Loa Loa (eye worm) | glutaminase 2 | 0.0266 | 0.8693 | 1 |
Loa Loa (eye worm) | multiple epidermal growth factor-like domains 6 | 0.0063 | 0.0262 | 0.0302 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.0947 | 0.1089 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0151 | 0.392 | 0.4509 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 4.1475 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 63.0957 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.